Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ACA | VFS |
|---|---|---|
| Price | $146.75 | $3.08 |
| Change today | ▲ 0.17% | ▲ 1.32% |
| Market cap | $7.21B | $7.21B |
| Return, 3 months | +1.4% | -1.0% |
| Return, year to date | +38.2% | -7.8% |
| Return, 1 year | +60.9% | -6.1% |
| P/E (TTM) | 14.7 | -1.6 |
| P/B | 2.4 | -0.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 0.14% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 66 | 46 |
| 30-day volatility | 2.4% | 35.7% |
| Max drawdown, 1 year | -21.4% | -40.1% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
